Pulmonary Fibrosis Treatment Market Share

On the basis of regional analysis, the pulmonary fibrosis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

Asia Pacific industry is predicted to dominate majority revenue share by 2037, driven by growing presence of leading companies involved in research and development activities for the manufacturing of effective drugs. Moreover, the increasing number of patients with pulmonary fibrosis in the region is a major factor estimated to resulting in the market growth over the forecast period. The Lung Foundation of Australia estimates that around 1,250 people in Australia are diagnosed with idiopathic pulmonary fibrosis every year. The market in North America is estimated to hold the leading share in the market as a result of growing research and developments in the area as well as presence of key players in the pulmonary fibrosis treatment market in this region.